Imunon
IMNN | NASDAQ
$0.59
-$0.04 (-6.20%)
At close: Nov 16, 2026, 4:00 PM ET
$0.59
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:46 PM ET
-6.20%
(1D)No price chart data available for 1D timeframe.
Rating
29.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #828/1021 (Top 81%)
Key Statistics
Market Data
Market Cap $3.51M
1D Range
0.56 0.64
52W Range
0.56 4.18
Valuation (TTM)
PE -0.15
PB 1.34
EV/EBITDA -0.45
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $10.00
Cash Flow
FCF Yield -397.4%
SBC Adj. FCF Yield -416.0%
SBC Impact -4.7%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
-90.0%
Dil EPS 3Y | 5Y 79.3% |
49.4%
FCF 3Y | 5Y 13.6% |
13.6%
Returns
ROA -125.2%
ROE -349.0%
ROIC -154.9%
Financial Health
Net Debt
$2.19M
Current Ratio 1.38
Interest Coverage -43.37
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Imunon, Inc. is a clinical-stage biotechnology company dedicated to the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. The company's pipeline fe...
Sector Healthcare
Industry Biotechnology
Employees 20
IPO Date Mar 1, 1999
Website www.imunon.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove IMNN